Publications by authors named "Maha M Adel Elgammal"
Page 1 of 1
Synopsis of recent research by authors named "Maha M Adel Elgammal"
- Maha M Adel Elgammal's recent research primarily investigates the role of the soluble decoy receptor 3 (DcR3) in B cell non-Hodgkin's lymphoma (NHL), particularly focusing on its relationship with the apoptosis inhibitor survivin and other prognostic factors.
- In her 2013 study, she analyzed 50 cases of diffuse large B cell non-Hodgkin's lymphoma (DLBCL) to determine the correlation between DcR3 and survivin expression levels.
- The findings highlighted a potential link between DcR3 expression and survivin, suggesting that both biomarkers may contribute to the pathogenesis of DLBCL and offer insights into prognostic assessments for patients.
